These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22071129)

  • 1. Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications.
    Laforce R; Rabinovici GD
    Alzheimers Res Ther; 2011 Nov; 3(6):31. PubMed ID: 22071129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.
    Carneiro CG; Faria DP; Coutinho AM; Ono CR; Duran FLS; da Costa NA; Garcez AT; da Silveira PS; Forlenza OV; Brucki SMD; Nitrini R; Busatto G; Buchpiguel CA
    Braz J Psychiatry; 2022 Aug; 44(5):495-506. PubMed ID: 36420910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
    Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
    Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Zhang S; Smailagic N; Hyde C; Noel-Storr AH; Takwoingi Y; McShane R; Feng J
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010386. PubMed ID: 25052054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
    Rabinovici GD; Furst AJ; O'Neil JP; Racine CA; Mormino EC; Baker SL; Chetty S; Patel P; Pagliaro TA; Klunk WE; Mathis CA; Rosen HJ; Miller BL; Jagust WJ
    Neurology; 2007 Apr; 68(15):1205-12. PubMed ID: 17420404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
    Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid imaging with (11)C-PIB PET/CT and glucose metabolism with (18)F-FDG PET/CT in a study on cognitive impairment in the clinical setting.
    Banzo I; Jiménez-Bonilla J; Ortega-Nava F; Quirce R; Martínez-Rodríguez I; de Arcocha-Torres M; Rodríguez E; Vázquez JL; Sánchez PJ; Martínez-Amador N; Ibañez-Bravo S; Carril JM
    Nucl Med Commun; 2014 Mar; 35(3):238-44. PubMed ID: 24240196
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Higashi T; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
    Ann Nucl Med; 2018 Apr; 32(3):206-216. PubMed ID: 29388083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia.
    Sheikh-Bahaei N; Sajjadi SA; Pierce AL
    Curr Treat Options Neurol; 2017 Nov; 19(12):46. PubMed ID: 29134465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral Blood Flow and Aβ-Amyloid Estimates by WARM Analysis of [
    Rodell AB; O'Keefe G; Rowe CC; Villemagne VL; Gjedde A
    Front Aging Neurosci; 2016; 8():321. PubMed ID: 28123366
    [No Abstract]   [Full Text] [Related]  

  • 12. Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update.
    Farid K; Charidimou A; Baron JC
    Neuroimage Clin; 2017; 15():247-263. PubMed ID: 28560150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Diagnosis Between Alzheimer's Disease-Related Depression and Pseudo-Dementia in Depression: A New Indication for Amyloid-β Imaging?
    Leonhardi J; Barthel H; Speerforck S; Dietzel J; Schroeter ML; Saur D; Tiepolt S; Rullmann M; Patt M; Claßen J; Schomerus G; Sabri O
    J Alzheimers Dis; 2022; 88(3):1029-1035. PubMed ID: 35723098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular neuroimaging in degenerative dementias.
    Jiménez Bonilla JF; Carril Carril JM
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):301-9. PubMed ID: 23933381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.
    Degerman Gunnarsson M; Lindau M; Santillo AF; Wall A; Engler H; Lannfelt L; Basun H; Kilander L
    Dement Geriatr Cogn Dis Extra; 2013 Jan; 3(1):472-81. PubMed ID: 24516415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected].
    Ma Y; Zhang S; Li J; Zheng DM; Guo Y; Feng J; Ren WD
    Medicine (Baltimore); 2014 Dec; 93(27):e150. PubMed ID: 25501055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
    Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G
    Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and acceptance of simultaneous amyloid PET/MRI.
    Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.
    Bensaïdane MR; Beauregard JM; Poulin S; Buteau FA; Guimond J; Bergeron D; Verret L; Fortin MP; Houde M; Bouchard RW; Soucy JP; Laforce R
    J Alzheimers Dis; 2016 Apr; 52(4):1251-62. PubMed ID: 27104896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.